Interestingly, the expression of the tumor suppressor gene p53 increased in a dose-dependent manner in vanillic acid-treated nanocomposite when compared to control cancer cells, suggesting that the nanocomposite might have stimulated apoptosis via a p53-dependent pathway. The gene discussed is TP53; the disease is cancer.